Solvent-free elastomer nanocomposite ink made by in situ exfoliation of 2D nanomaterials for extrusion-based 3D printing of porous membranes and scaffolds at micrometer resolution. Enables flexible desalination membranes, heat-spreading meshes, and other functional structures with enhanced mechanical, thermal, and electrical performance at low cost and reduced environmental impact.
This technology provides a low-cost, solvent-free elastomer nanocomposite ink designed for extrusion-based 3D microprinting of porous fibrous structures. By exfoliating two-dimensional nanomaterials such as graphene and hexagonal boron nitride directly within a silicone elastomer matrix, the process produces a printable ink capable of fabricating flexible porous membranes and scaffolds with micrometer-sized pores. The in situ shear exfoliation approach uses bulk starting materials, eliminating the need for expensive pre-processed nanofillers or additives and reducing both cost and environmental impact. Mild plasma treatment can be applied post-printing to tune wettability, enabling hydrophilic behavior where needed.
Key features:
The underlying nanocomposite approach has been validated in published work demonstrating mechanical, thermal, and electrical performance gains, and the technology is protected by a granted patent. Planned next-stage validation includes preparing and rheologically characterizing the nanocomposite ink, printing test structures using a customized micro-nozzle printhead, and evaluating microscopic, spectroscopic, mechanical, thermal, wettability, and optical properties of printed samples. The work targets micrometer-scale resolution printing of porous fibrous analogs suitable for membrane, thermal management, and scaffold applications.
A comprehensive public research university with multiple campuses across the Tampa Bay region, USF combines scale with an applied, partnership‑driven culture. A research and technology park anchors co‑located corporate R&D, startups, and shared facilities that enable prototyping and testing. USF Health’s connection to a major hospital system and nearby specialty clinics supports clinical studies, device validation, and translational collaborations. Research is supported by competitive federal funding from agencies such as NIH, NSF, and DoD. A dedicated technology transfer office and research foundation manage IP, licensing, industry agreements, and venture creation, with incubator and accelerator resources in the park.